Metabolic Reprogramming in Brain Tumor Cells Could Be Potential Target


Contact: Katie Pence
(513) 558-4561

During a membership event April 29, the Cincinnati Cancer Center awarded over $200,000 in pilot grants to members and basic scientists who are collaborating to find out more about various cancers with hopes of generating more data and additional funding.

Three teams received Affinity Group Awards, which encourage multidisciplinary research efforts and link CCC programs.

Cancer doesn’t just happen.

It takes a lot for a normal cell to become cancerous.

“Rogue cells are usually instantly detected and our body does a pretty good job of getting rid of them,” says CCC member Biplab Dasgupta, PhD, assistant professor in the department of pediatrics at the UC College of Medicine and a member of the Cancer and Blood Diseases Institute at Cincinnati Children’s Hospital Medical Center. “The saga usually begins with a mutation or any other biochemical change in the chromosome of a normal cell that somehow manages to stay on, allowing other genetic or biochemical changes to occur. These cells alter their metabolism in order to grow and spread and are hungry for specific types of food. Unfortunately, the dietary habits of humans are much to blame for the growth and spread of these rogue cells.

“It is a combination of several unfortunate events that leads to the establishment and spread of cancer—sometimes it takes decades.”

Dasgupta’s lab is studying some of these initial events in cancer formation.

Now, with a $60,000 CCC affinity grant, he, along with CCC investigators Christopher McPherson, MD, a neurosurgeon and brain tumor specialist and a member of the UC Neuroscience and UC Cancer institutes, and Kakajan Komurov, PhD, assistant professor in the department of pediatrics at the UC College of Medicine and member of the Cancer and Blood Disease Institute at Cincinnati Children’s, is specifically studying metabolic reprogramming in brain tumor cells and how that can be targeted to inhibit tumor growth.

“In preliminary studies, we found that, compared to normal brain cells, patient-derived brain cancer cells express significantly more amounts of a protein called AMP kinase,” he says. “This protein is very important for metabolic programming of cancer cells. We want to see if blocking the function of the protein in the tumor cells blocks tumor formation in animal models, and if it does, whether a chemical inhibitor can be used as a potential treatment for brain cancer.”

He says the Cancer Genome Atlas provides a lot of data about mutations associated with various types of cancer.

“There are ‘driver’ mutations and ‘passenger’ mutations associated with certain genes,” Dasgupta explains. “The ‘driver’ mutations’ roles are mostly known; however, very little is known about the role of the ‘passenger’ mutations. When a driver gene gets deleted, other genes (passengers) around it also get deleted, many of which remain unnoticed and understudied because of the dominant role of the driver gene. We are examining when a driver gene gets deleted, whether it takes one or more important passenger genes with it and if this makes some brain tumors vulnerable to certain drugs.”

Besides helping to treat brain tumors, he adds that this data could also help with the treatment of other tumors.

“This grant is a tremendous help, as we do not have money allocated for novel projects like this,” Dasgupta says. “Without this money, we probably wouldn’t be able to do this kind of research that is so important for generating data that could potentially lead to more funding from the National Institutes of Health. We are very grateful.”

The University of Cincinnati, Cincinnati Children’s Hospital Medical Center and UC Health have created the Cincinnati Cancer Center—a joint effort designed to leverage the strengths of all three organizations in order to provide the best possible cancer diagnostics, research, treatment, and care for individuals in the Tristate region and the nation. To learn more, visit

This entry was posted in Press Releases. Bookmark the permalink. Both comments and trackbacks are currently closed.
  • Print This Page
  • Make an Appointment: Schedule Now
  • Sign up for our newsletter!
  • Hope Stories

    • Jim’s Story: Acromegaly / Pituitary Tumor

      Jim's Story: Acromegaly / Pituitary Tumor Four years later, Jim’s story just keeps getting better. Because four years after being treated for a pituitary tumor at the UC Brain Tumor Center, Jim continues to feel better and better. The size of his head has gone down....
    • Bob’s Story: Recurrent Glioblastoma

      Bob's Story: Recurrent Glioblastoma Glioblastomas come back. Sometimes sooner, sometimes later, but they always come back. “That’s the...
    • Troy’s Testimonial: ‘Out of 5 Stars, They Get 6’

      Troy’s Testimonial: ‘Out of 5 Stars, They Get 6’ Troy Sheldon has something to say, and he’d like...
    • Jerry’s Story: Spinal Tumor

      Jerry's Story: Spinal Tumor On an ordinary day in February 2009, John M. Tew, MD, got one of the true surprises of his career. He was seeing patients in his Mayfield Clinic office on the University of Cincinnati medical campus when an unexpected guest...
    • Lynne’s Story: Brain Metastasis

      Lynne's Story: Brain MetastasisSemiretired and working part-time at a restaurant, Lynne knew something was amiss when she looked at the cash register and then struggled to make her hands produce the correct amount of change. Could she have suffered a stroke? Lynne pushed the...
    • Troy’s Story: Proton Therapy for Brain Cancer

      Troy's Story: Proton Therapy for Brain Cancer Troy Witt, 65, a London, Kentucky resident and a self-proclaimed "country boy,” says he loves his family, fishing, woodworking and riding on his tractor. But all of these activities have been put on hold since spring 2016 when Witt’s...
    • Brian’s Story: Meningioma

      Brian's Story: Meningioma “Carefree” is the word Brian uses to describe his life back then. He was 39 years old, happily married and the father of three children under the age of 5. “Life was busy, but that felt normal,” he says, reflecting. “The only...